📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy. (2012)

First Author: Griesenbach U

Attributed to: Development of a novel, potent, safe, long-lasting lentivirus-based gene therapy for cystic fibrosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201206-1056oc

PubMed Identifier: 22955314

Publication URI: http://europepmc.org/abstract/MED/22955314

Type: Journal Article/Review

Volume: 186

Parent Publication: American journal of respiratory and critical care medicine

Issue: 9

ISSN: 1073-449X